Drug transporter expression in human macrophages

Fundamental and Clinical Pharmacology

Volumn 25, Issue 6, 2011, Pages 743-752

  Moreau, Amélie ^a,b   Le Vee, Marc ^a   Jouan, Elodie ^a   Parmentier, Yannick ^b   Fardel, Olivier ^a,c  

^a UNIVERSITÉ DE RENNES 1   (France)

^b INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^c PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

Cellular pharmacokinetics; Lipopolysaccharide; Macrophages; Monocarboxylate transporters; Multidrug resistance proteins; Nucleoside transporters

Indexed keywords

ABC TRANSPORTER; ANTILEISHMANIAL AGENT; ANTINEOPLASTIC AGENT; BETA LACTAM ANTIBIOTIC; CARBOXY 2',7' DICHLOROFLUORESCEIN; CYCLOSPORIN A; DICHLOROFLUORESCEIN; DIDANOSINE; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 3; FUMITREMORGIN C; GANCICLOVIR; GLYCOPROTEIN P; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPOPOLYSACCHARIDE; MEMBRANE PROTEIN; MEMBRANE PROTEIN CNT3; MEMBRANE PROTEIN PHT1; MEMBRANE PROTEIN PHT2; MESSENGER RNA; MONOCARBOXYLATE TRANSPORTER 1; MONOCARBOXYLATE TRANSPORTER 4; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; PENICILLIN G; UNCLASSIFIED DRUG; UNINDEXED DRUG; URIDINE; VERAPAMIL; ZALCITABINE; ZIDOVUDINE;

ARTICLE; CONTROLLED STUDY; DRUG TRANSPORT; GENE EXPRESSION; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL;

ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; CELLS, CULTURED; FLUORESCEINS; GENE EXPRESSION; HUMANS; LACTIC ACID; MACROPHAGES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA, MESSENGER;

EID: 80051956180     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2010.00913.x     Document Type: Article

References (40)

1. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. (2008) 8 958-969.
2. Aquaro S., Bagnarelli P., Guenci T. et al. Long-term survival and virus production in human primary macrophages infected by human immunodeficiency virus. J. Med. Virol. (2002) 68 479-488.
3. Paton J.H., Reeves D.S. Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use. Drugs (1988) 36 193-228.
4. Ojewole E., Mackraj I., Naidoo P., Govender T. Exploring the use of novel drug delivery systems for antiretroviral drugs. Eur. J. Pharm. Biopharm. (2008) 70 697-710.
5. Skazik C., Heise R., Bostanci O. et al. Differential expression of influx and efflux transport proteins in human antigen presenting cells. Exp. Dermatol. (2008) 17 739-747.
6. Minuesa G., Purcet S., Erkizia I. et al. Expression and functionality of anti-human immunodeficiency virus and anticancer drug uptake transporters in immune cells. J. Pharmacol. Exp. Ther. (2008) 324 558-567.
7. Leite D.F., Echevarria-Lima J., Ferreira S.C., Calixto J.B., Rumjanek V.M. ABCC transporter inhibition reduces zymosan-induced peritonitis. J. Leukoc. Biol. (2007) 82 630-637.
8. Lemarie A., Morzadec C., Bourdonnay E., Fardel O., Vernhet L. Human macrophages constitute targets for immunotoxic inorganic arsenic. J. Immunol. (2006) 177 3019-3027.
9. Lecureur V., Le Ferrec E., N'Diaye M. et al. ERK-dependent induction of TNFalpha expression by the environmental contaminant benzo(a)pyrene in primary human macrophages. FEBS Lett. (2005) 579 1904-1910.
10. van Grevenynghe J., Rion S., Le Ferrec E. et al. Polycyclic aromatic hydrocarbons inhibit differentiation of human monocytes into macrophages. J. Immunol. (2003) 170 2374-2381.
11. Jigorel E., Le Vee M., Boursier-Neyret C., Parmentier Y., Fardel O. Differential regulation of sinusoidal and canalicular hepatic drug transporter expression by xenobiotics activating drug-sensing receptors in primary human hepatocytes. Drug Metab. Dispos. (2006) 34 1756-1763.
12. Lecureur V., Fardel O., Guillouzo A. The antiprogestatin drug RU 486 potentiates doxorubicin cytotoxicity in multidrug resistant cells through inhibition of P-glycoprotein function. FEBS Lett. (1994) 355 187-191.
13. Fardel O., Payen L., Courtois A., Drenou B., Fauchet R., Rault B. Differential expression and activity of P-glycoprotein and multidrug resistance-associated protein in CD34-positive KG1a leukemic cells. Int. J. Oncol. (1998) 12 315-319.
14. Laupeze B., Amiot L., Drenou B. et al. High multidrug resistance protein activity in acute myeloid leukaemias is associated with poor response to chemotherapy and reduced patient survival. Br. J. Haematol. (2002) 116 834-838.
15. Jigorel E., Le Vee M., Boursier-Neyret C., Bertrand M., Fardel O. Functional expression of sinusoidal drug transporters in primary human and rat hepatocytes. Drug Metab. Dispos. (2005) 33 1418-1422.
16. Le Vee M., Lecureur V., Stieger B., Fardel O. Regulation of drug transporter expression in human hepatocytes exposed to the proinflammatory cytokines tumor necrosis factor-alpha or interleukin-6. Drug Metab. Dispos. (2009) 37 685-693.
17. Leite D.F., Echevarria-Lima J., Calixto J.B., Rumjanek V.M. Multidrug resistance related protein (ABCC1) and its role on nitrite production by the murine macrophage cell line RAW 264.7. Biochem. Pharmacol. (2007) 73 665-674.
18. Szatmari I., Vamosi G., Brazda P. et al. Peroxisome proliferator-activated receptor gamma-regulated ABCG2 expression confers cytoprotection to human dendritic cells. J. Biol. Chem. (2006) 281 23812-23823.
19. Pastor-Anglada M., Cano-Soldado P., Molina-Arcas M. et al. Cell entry and export of nucleoside analogues. Virus Res. (2005) 107 151-164.
20. Meaden E.R., Hoggard P.G., Newton P. et al. P-glycoprotein and MRP1 expression and reduced ritonavir and saquinavir accumulation in HIV-infected individuals. J. Antimicrob. Chemother. (2002) 50 583-588.
21. Sasabe H., Kato Y., Suzuki T., Itose M., Miyamoto G., Sugiyama Y. Differential involvement of multidrug resistance-associated protein 1 and P-glycoprotein in tissue distribution and excretion of grepafloxacin in mice. J. Pharmacol. Exp. Ther. (2004) 310 648-655.
22. Dallas S., Ronaldson P.T., Bendayan M., Bendayan R. Multidrug resistance protein 1-mediated transport of saquinavir by microglia. Neuroreport (2004) 15 1183-1186.
23. Michot J.M., Van Bambeke F., Mingeot-Leclercq M.P., Tulkens P.M. Active efflux of ciprofloxacin from J774 macrophages through an MRP-like transporter. Antimicrob. Agents Chemother. (2004) 48 2673-2682.
24. Marquez B., Caceres N.E., Mingeot-Leclercq M.P., Tulkens P.M., Van Bambeke F. Identification of the efflux transporter of the fluoroquinolone antibiotic ciprofloxacin in murine macrophages: studies with ciprofloxacin-resistant cells. Antimicrob. Agents Chemother. (2009) 53 2410-2416.
25. Mookerjee Basu J., Mookerjee A., Banerjee R. et al. Inhibition of ABC transporters abolishes antimony resistance in Leishmania Infection. Antimicrob. Agents Chemother. (2008) 52 1080-1093.
26. Vernhet L., Courtois A., Allain N. et al. Overexpression of the multidrug resistance-associated protein (MRP1) in human heavy metal-selected tumor cells. FEBS Lett. (1999) 443 321-325.
27. Itoh T., Tanno M., Li Y.-H., Yamada H. Transport of phenethicillin into rat intestinal brush border membrane vesicles: role of the monocarboxylic acid transport system. Int. J. Pharm. (1998) 172 103-112.
28. Puig-Kroger A., Sierra-Filardi E., Dominguez-Soto A. et al. Folate receptor beta is expressed by tumor-associated macrophages and constitutes a marker for M2 anti-inflammatory/regulatory macrophages. Cancer Res. (2009) 69 9395-9403.
29. Soler C., Garcia-Manteiga J., Valdes R. et al. Macrophages require different nucleoside transport systems for proliferation and activation. FASEB J. (2001) 15 1979-1988.
30. Laupeze B., Amiot L., Bertho N. et al. Differential expression of the efflux pumps P-glycoprotein and multidrug resistance-associated protein in human monocyte-derived dendritic cells. Hum. Immunol. (2001) 62 1073-1080.
31. Robbiani D.F., Finch R.A., Jager D., Muller W.A., Sartorelli A.C., Randolph G.J. The leukotriene C(4) transporter MRP1 regulates CCL19 (MIP-3beta, ELC)-dependent mobilization of dendritic cells to lymph nodes. Cell (2000) 103 757-768.
32. van de Ven R., de Jong M.C., Reurs A.W. et al. Dendritic cells require multidrug resistance protein 1 (ABCC1) transporter activity for differentiation. J. Immunol. (2001) 176 5191-5198.
33. Fardel O., Le Vee M. Regulation of human hepatic drug transporter expression by pro-inflammatory cytokines. Expert Opin. Drug Metab. Toxicol. (2009) 5 1469-1481.
34. Turriziani O., Gianotti N., Falasca F. et al. Expression levels of MDR1, MRP1, MRP4 and MRP5 in peripheral blood mononuclear cells from HIV infected patients failing antiretroviral therapy. J. Med. Virol. (2008) 80 766-771.
35. Morgan E.T., Goralski K.B., Piquette-Miller M. et al. Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer. Drug Metab. Dispos. (2008) 36 205-216.
36. Donnenberg V.S., Burckart G.J., Griffith B.P., Jain A.B., Zeevi A., Berg A.D. P-glycoprotein (P-gp) is upregulated in peripheral T-cell subsets from solid organ transplant recipients. J. Clin. Pharmacol. (2001) 41 1271-1279.
37. Silverstein P.S., Audus K.L., Qureshi N., Kumar A. Lipopolysaccharide increases the expression of multidrug resistance-associated protein 1 (MRP1) in RAW 264.7 macrophages. J. Neuroimmune Pharmacol. (2010) 5 516-520.
38. Macdonald J., Galley H.F., Webster N.R. Oxidative stress and gene expression in sepsis. Br. J. Anaesth. (2003) 90 221-232.
39. Keppler D. Export pumps for glutathione S-conjugates. Free Radic. Biol. Med. (1999) 27 985-991.
40. Hirrlinger J., Konig J., Keppler D., Lindenau J., Schulz J.B., Dringen R. The multidrug resistance protein MRP1 mediates the release of glutathione disulfide from rat astrocytes during oxidative stress. J. Neurochem. (2001) 76 627-636.